RxDoctor Payments Data

Damon Hill, MD

Family Medicine · Lubbock, TXNPI 1427148352

Payments from drug & device makers

$2,088in general payments, 2019–2025

Across 107 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$342
  • Astellas Pharma US Inc$300
  • Pfizer$163
  • AstraZeneca$143
  • Lilly USA, LLC$134
  • Bayer$129
  • plus $877 from 20 others

What the payments were for

  • Food & beverage$1,89091%
  • Education$1989%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,088 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$85,263
Medicare patients
118
Services billed
1,067

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin49$71,371
OtezlaApremilast12$55,059
LinzessLinaclotide48$42,088
OzempicSemaglutide27$34,985
Soliqua 100-33Insulin Glargine/Lixisenatide27$31,303
MounjaroTirzepatide29$30,703
JanuviaSitagliptin Phosphate33$29,936
XareltoRivaroxaban39$26,183
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen730$23,364
FarxigaDapagliflozin Propanediol25$22,421
VraylarCariprazine Hcl15$21,652
TrulicityDulaglutide18$19,614
MyrbetriqMirabegron21$18,825
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$16,390
EliquisApixaban28$16,131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Trijardy Xr, Jentadueto, Synjardy$33$88,90591 claims
AbbVieLinzess, Vraylar$342$63,74063 claims
AmgenOtezla$82$55,05912 claims
Lilly USA, LLCMounjaro, Trulicity$134$50,31747 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$143$40,41257 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$120$35,42043 claims
Novo NordiskOzempic$67$34,98527 claims
Astellas Pharma US IncMyrbetriq$300$18,82521 claims
GSKTrelegy Ellipta$35$16,39021 claims
PfizerEliquis$163$16,13128 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$27$8,50317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Lubbock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →